Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4247530 | Radiologic Clinics of North America | 2008 | 13 Pages |
Abstract
Fully diagnostic positron emission tomography (PET)/CT scans acquired during oral and intravenous contrast can be provided to patients and referring physicians in a single imaging session. Although FDG uptake varies, most low-grade lymphomas exhibit sufficient FDG avidity to also be staged reliably with FDG PET/CT. PET/CT imaging is more accurate for lymphoma staging than PET or CT alone and has substantial impact on patient management. This accurate whole-body glucose metabolic survey should serve as the baseline for subsequent treatment response evaluations. PET/CT has evolved to become the modality of choice for staging of nodal and extranodal lymphoma, for assessing therapeutic response, and for establishing patient prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Martin Allen-Auerbach, Sven de Vos, Johannes Czernin,